The health system partnered with Brooks Automation, an automation and cryogenic solutions provider, to complete construction of the biobank. Brooks Life Sciences, a sample management solutions provider and division of Brooks Automation, will manage onsite operations at the facility, including storage of biological specimens.
The biobank will support Cleveland Clinic’s ability to analyze patient’s biological specimens by providing a centralized facility to store and manage various tissue samples. Cleveland Clinic officials hope the biobank will help the hospital advance its personalized medicine research on a range of conditions, including cancer, heart disease and epilepsy.
“Biobanking is essential for the evolution of personalized medicine,” Serpil Erzurum, MD, chair of Cleveland Clinic Lerner Research Institute, said in a May 21 statement. “The ability to properly manage biological specimens and to compare diseased tissues side-by-side with healthy tissues is essential to understanding the biological basis of a disease.”
More articles on data analytics & precision medicine:
Study predicts patients’ disease risks using emergency contacts
Intermountain expands precision genomics DNA test to all providers
UCSF Health, UChicago Medicine partner with Color to offer patients genetic tests
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
